文献速递前列腺癌

双参数与多参数磁共振诊断前列腺癌的性能:更新系统综述与荟萃分析

Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis.
PubMed 文献 · Eur Urol · 2026-02-16

该更新系统综述与荟萃分析纳入40项头对头研究共9403例疑似前列腺癌男性,比较双参数MRI(bpMRI)与多参数MRI(mpMRI)对临床显著前列腺癌(csPC)的诊断准确性。患者水平上,bpMRI对csPC的敏感性和特异性均非劣于mpMRI;病灶水平上特异性非劣但敏感性未达非劣。

要点

  • 患者水平bpMRI对csPC检测非劣于mpMRI,敏感性差-2.3%、特异性差+1.8%。
  • 病灶水平bpMRI特异性非劣,但敏感性未达非劣效界值。
  • 推广bpMRI需确保图像质量,并需进一步定义最低质量控制标准。

核心结论

  • 患者水平bpMRI对csPC检测非劣于mpMRI。
  • 病灶水平bpMRI仅特异性非劣,敏感性未达非劣。

研究设计与样本

  • 更新系统综述与荟萃分析,检索截至2025年9月。
  • 纳入40项头对头研究,共9403例疑似前列腺癌男性。
  • 以活检或前列腺切除为参考标准。
  • 非劣效界值为配对绝对差-5%,采用随机效应模型。

主要发现

  • csPC患者水平敏感性配对绝对差-2.3%(95%CI -4.1%至-0.5%)。
  • csPC患者水平特异性配对绝对差+1.8%(95%CI -0.4%至+4.0%)。
  • 病灶水平bpMRI特异性非劣,敏感性未达非劣,可能因研究少、异质性大。

临床怎么用

  • 在图像质量有保障的机构可推广bpMRI用于csPC检测。
  • 需进一步研究定义采纳bpMRI所需的最低质量控制标准。

局限性

  • 病灶水平分析研究数量较少且异质性较大,敏感性非劣未证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Multiparametric magnetic resonance imaging (mpMRI) is the reference modality for detecting clinically significant prostate cancer (csPC). Biparametric MRI (bpMRI), which omits contrast, has emerged as a streamlined alternative. Recent studies have demonstrated the noninferiority of bpMRI to mpMRI for csPC detection in biopsy-naïve men. We performed an updated systematic review and meta-analysis of head-to-head studies comparing bpMRI and mpMRI for csPC detection, and conducted a noninferiority analysis. METHODS: Literature databases were searched up to September 2025 for head-to-head studies. Eligible studies enrolled men with suspected PC and used biopsy or prostatectomy as the reference standard. The primary outcome was diagnostic accuracy for csPC at per-patient and per-lesion levels; detection of any PC was a secondary outcome. Noninferiority was assessed using a margin of -5% applied to paired absolute differences (bpMRI - mpMRI) in sensitivity and specificity via a random-effects model. KEY FINDINGS AND LIMITATIONS: A total of 40 studies (9403 patients) were analyzed. For csPC, the paired absolute differences were -2.3% (95% confidence interval [CI] -4.1% to -0.5%) for sensitivity, and +1.8% (95% CI -0.4% to +4.0%) for specificity, which confirm noninferiority at the patient level. At the lesion level, bpMRI was noninferior for specificity but not sensitivity, probably because of fewer studies and greater heterogeneity. CONCLUSIONS AND CLINICAL IMPLICATIONS: bpMRI is noninferior to mpMRI for csPC detection at the patient level. At the per-lesion level, noninferiority was demonstrated for specificity but not for sensitivity. Broader implementation should occur in settings with assured image quality, and further work is needed to define minimum quality-control standards required for adoption.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Strieder de Oliveira G, Altmayer S, Torri GB, et al. Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis. Eur Urol. 2026. PMID: 41702800. doi:10.1016/j.eururo.2026.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。